The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer.

Among recipients with HIV, kidney transplantation from donors with HIV is noninferior to that from donors without HIV.

A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...

Fostemsavir plus optimized background therapy was associated with improvements in immune biomarkers among HTE patients with MDR HIV infection.

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

The healthcare sector has been a focal point for investors in 2024, offering a compelling blend of innovation-driven ...